FDA Investigator: Prajakta A. Varadkar
- Prajakta A. Varadkar first started conducting FDA inspections in 2018, with the last inspection in 2024. Over that time, Prajakta A. Varadkar has conducted 7 inspections at 7 companies across 7 sites.
Get Prajakta Varadkar's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Boehringer Ingelheim RCV GmbH & Co KG, Vienna | 2023
Out-of-stock
Prajakta A. Varadkar
Biologics Form 483
FDA 483 Charles River Laboratories Inc, Memphis | 2023
Out-of-stock
Prajakta A. Varadkar
Biologics Form 483
FDA 483 Kamada Ltd., Mobile Post Negev | 2023
Out-of-stock
Prajakta A. Varadkar
Biologics Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2022
Out-of-stock
Prajakta A. Varadkar
Biologics Form 483
FDA 483 CellTrans Inc., Chicago | 2021
Out-of-stock
Prajakta A. Varadkar
Biologic Form 483
FDA 483 Abraham J & Phyllis Katz Cord Blood Foundation, Cleveland | 2018
Out-of-stock
Prajakta A. Varadkar
Biologic Form 483
Co-Investigators (14)
- Sharmila Shrestha, FDA Investigator
- Pankaj H. Amin, FDA Investigator
- Zhaohui Ye, FDA Investigator
- Donald B. Ertel, FDA Investigator
- Wei Wang, FDA Investigator
- Hoda N. Abadeer, FDA Investigator
- Jessica Chery,
- Olga Simakova, FDA Investigator
- Gregory A. Price, FDA Investigator
- Alifiya H. Ghadiali, FDA Investigator
- Daniel Lagasse, FDA Investigator
- Gene D. Arcy, FDA Investigator
- Nancy L. Neiger, FDA Investigator
- Simone E. Pitts, FDA Investigator